As one of the largest and comprehensive laws firms in China, Tian Yuan's practice areas cover a wide range of capital markets, corporate/M&A, dispute resolution, financial & asset management, antitrust/competition, private affairs & wealth management, education, healthcare, pharmaceuticals and life science, PE/VC, TMT, fin-tech, Belt & Road/cross-border investment, real estate, construction, infrastructure and project finance(PPP), restructuring & insolvency, labour and employment, regulatory and compliance, etc. Meanwhile, Tian Yuan continues to develop and expand into new practice areas or provide new legal service modes.

• Asset finance
• Banking
• Capital markets: Debt
• Capital markets: Derivatives
• Capital markets: Equity
• Capital markets: High yield
• CLO/CDO
• Competition
• Covered bonds
• Financial restructuring
• Financial services regulatory
• Hedge funds
• Investment funds
• Islamic finance
• M&A
• PPP/PFI
• Private equity
• Private equity funds
• Project bonds
• Project development
• Project finance
• Real estate finance
• Real estate funds
• Restructuring and insolvency
• Securitisation
• Structured finance/securitisation
• Trade finance

ALL Key Practice Contacts: marketing@tylaw.com.cn

Recent transactional highlights:

Capital markets: Domestic Issuances

• Tian Yuan has advised CanSino, Junshi BioPharma, M&S Electronics, Delinhai, United Winners Laser, Rockontrol, Willfar Information Technology, Kingsemi, Lifotronic, Haier Biomedical, Friendess Electronics, Traffic Control Technology and other innovative companies on their listings on the STAR Market.
• Since the launch of registration-based IPO system on ChiNext, Tian Yuan has advised several innovative companies such as Shengyuan Environmental Protection, Jieqiang Equipment and Jinlongyu to complete registration.

Capital markets: Hong Kong and Overseas Issuances

• Recently, Tian Yuan has advised Akeso, Ocumension Therapeutics, InnoCare Pharma, Hepalink, Kangji Medical, Hygeia Healthcare, Nongfu Spring, Archosaur Games, Cathay Media and Education, Financial Street Property, Central China New Life, Jianzhong Construction Development on their listings in Hong Kong. 

Investment/M&A

• Advised China Yangtze Power on its USD3.59 billion acquisition of Luz Del Sur, Peru's largest listed electricity company. This is the largest overseas energy M&A transaction among Chinese enterprises in recent years, and also the world’s largest M&A transaction in the power industry within the past three years and the most important global M&A transaction recently;
• Advised Willsemi on its RMB15.5 billion acquisition of Beijing Omnivision, a world-famous image sensor chip supplier. This was one of the most influential cross-border M&A transactions in the semiconductor industry in 2019;
• Advised Sinochem Group on obtaining control of Luxi Group and the listed company Luxi Chemical;
• Advised Sinochem Energy on its over RMB10 billion capital increase and introducing strategic investors;
• Advised Fujia Group on its RMB22.8 billion joint acquisition of Hexie Health;
• Advised Junzheng Group on its RMB10.8 billion transfer of Huatai Insurance;
• Advised China Cinda on its RMB7.5 billion transfer of Happy Life Insurance.

• Accounting
• Agriculture
• Automotive
• Aviation
• Banking
• Construction and materials
• Consumer goods and services
• Energy
• Financial services
• Fisheries and aquaculture
• Food and beverage
• Forestry
• Gaming
• Government and public policy
• Healthcare
• Industrials
• Insurance
• Investment management
• Media
• Mining
• Natural resources
• Oil and gas
• Pharm and life sciences
• Real estate
• Shipping
• Social infrastructure
• Tech and telecoms
• Tourism
• Transport
• Utilities

Beijing, Shanghai, Shenzhen, Chengdu, Hong Kong, Hangzhou, Xi’an, Haikou, Suzhou